| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Xenon Pharmaceuticals Inc. (XENE) has 12 insiders with recent SEC Form 4 filings, including 0 buys and 38 sells. XENE is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 225.0K | $12.73M | - | |
| Other | 40.0K | $2.26M | - | |
| CEO | 19.9K | $1.13M | - | |
| Dir | 17.0K | $962.4K | - | |
| Dir | 17.0K | $962.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 24, 2023 | Mortimer Ian53 | President &CEO | Sale+OE | 31,655 | $41.41 | $1,310,931.02 | -27.6% | -7.3% | -7.1% | |
| Mar 24, 2023 | Kenney Christopher John | Chief Medical Officer | Sell | 700 | $35.01 | $24,507.00 | -100% | +16.0% | +25.5% | |
| Mar 7, 2023 | Pimstone Simon N.60 | Director | Sale+OE | 19,232 | $36.98 | $711,199.38 | -17.8% | +9.6% | +27.5% | |
| Nov 25, 2022 | Patou Gary50 | Director | Sale+OE | 3,994 | $34.55 | $137,999.97 | -7.8% | +10.1% | -16.8% | |
| Sep 2, 2022 | Aulin Sherry | Chief Financial Officer | Sale+OE | 15,355 | $39.57 | $607,597.35 | -100% | -5.3% | +1.9% | |
| Sep 1, 2022 | Robin Sherrington50 | EVP, Strategy &Innovation | Sale+OE | 65,231 | $38.31 | $2,499,022.53 | -52.4% | -6.7% | +0.5% | |
| Aug 16, 2022 | Pimstone Simon N.60 | Director | Sell | 177,135 | $38.25 | $6,775,148.59 | -29.9% | -10.2% | -4.5% | |
| Aug 12, 2022 | Empfield James R.47 | EVP, Drug Discovery | Sale+OE | 57,743 | $38.31 | $2,211,978.44 | -58.0% | -8.2% | -0.5% | |
| Mar 8, 2022 | Pimstone Simon N.60 | Director | Sale+OE | 54,962 | $29.28 | $1,609,320.57 | -1.8% | -1.6% | +18.9% | |
| Mar 7, 2022 | Empfield James R.47 | EVP, Drug Discovery | Sale+OE | 51,168 | $30.63 | $1,567,393.87 | -45.6% | -0.9% | +19.3% |